Sign In
Buy OBSV
$0.102
+0 (+0%)
At Close: Jun 21, 2023
ObsEva Announces Sale of Ebopiprant License Agreement to XOMA for up to $113 Million
06:00am, Tuesday, 22'nd Nov 2022 GlobeNewswire Inc.
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange
ObsEva Announces Progress on Cost Reduction Initiatives and Stay of Moratorium Proceedings
09:00pm, Wednesday, 26'th Oct 2022 GlobeNewswire Inc.
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange
ObsEva Announces IND Approval for Yuyuan Bioscience’s Phase 1 Clinical Trial of Nolasiban in China
11:00am, Thursday, 13'th Oct 2022 GlobeNewswire Inc.
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange
Why Norwegian Cruise Line Shares Climbed By Around 12%; Here Are 66 Biggest Movers From Yesterday
10:06am, Thursday, 13'th Oct 2022 Benzinga
Gainers
Pintec Technology Holdings Limited (NASDAQ: PT) shares jumped 216.2% to close at $0.9058 on Wednesday.
Agrify Corporation (NASDAQ: AGFY) climbed 88% to close at $ 0.9540 on Wednesday after cl
ObsEva Announces IND Approval for Yuyuan Bioscience’s Phase 1 Clinical Trial of Nolasiban in China
05:00am, Thursday, 13'th Oct 2022 GlobeNewswire Inc.
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange
Why T2 Biosystems Shares Are Trading Lower By Over 28%, Here Are 41 Stocks Moving In Wednesday's Mid-Day Session
04:00pm, Wednesday, 12'th Oct 2022 Benzinga
Gainers
Code Chain New Continent Limited (NYSE: CCNC) shares jumped 74% to $0.2868 after declining around 14% on Tuesday.
FLJ Group Limited (NASDAQ: FLJ) gained 69% to $2.59.
Hempacco Co., Inc. (NAS
Why Cango Shares Are Trading Higher; Here Are 27 Stocks Moving Premarket
11:19am, Wednesday, 12'th Oct 2022 Benzinga
Gainers
Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) rose 43.2% to $0.2097 in pre-market trading after jumping over 16% on Tuesday. Adamis Pharmaceuticals recently announced a review of strateg
Why Vicinity Motor Is Trading Higher By Over 65%; Here Are 26 Stocks Moving Premarket
10:54am, Wednesday, 05'th Oct 2022 Benzinga
Gainers
Vicinity Motor Corp. (NASDAQ: VEV) rose 65.4% to $1.72 in pre-market trading. Vicinity Motor started deliveries of the first Class 3 electric truck to roll off the assembly line in Canada.
SH
ObsEva Announces Progress on Restructuring Initiatives
11:00am, Tuesday, 13'th Sep 2022 GlobeNewswire Inc.
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange
ObsEva Announces Progress on Restructuring Initiatives
05:00am, Tuesday, 13'th Sep 2022 GlobeNewswire Inc.
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange
Why DWAC Is Trading Lower By Around 19%; Here Are 32 Stocks Moving Premarket
10:41am, Tuesday, 06'th Sep 2022 Benzinga
Gainers
First Wave BioPharma, Inc. (NASDAQ: FWBI) shares rose 39.6% to $4.44 in pre-market trading after gaining 7% on Friday.
Organovo Holdings, Inc. (NASDAQ: ONVO) rose 25.1% to $2.89 in pre-marke
Why Okta Is Trading Lower By Over 32%, Here Are 58 Stocks Moving In Thursday's Mid-Day Session
04:47pm, Thursday, 01'st Sep 2022 Benzinga
Gainers
ShiftPixy, Inc. (NASDAQ: PIXY) jumped 94.4% to $27.24. ShiftPixy announced a 1-for-100 reverse stock split.
Hempacco Co., Inc. (NASDAQ: HPCO) shares climbed 63% to $8.33 after dropping 34% on
Why Nutanix Is Trading Higher By 16%; Here Are 33 Stocks Moving Premarket
11:00am, Thursday, 01'st Sep 2022 Benzinga
Gainers
Bright Green Corporation (NASDAQ: BGXX) shares rose 63.8% to $2.26 in pre-market trading after gaining around 33% on Wednesday.
Hempacco Co., Inc. (NASDAQ: HPCO) shares rose 53.2% to $7.83 in
Why Nuwellis Surged Over 121%; Here Are 66 Biggest Movers From Yesterday
09:19am, Thursday, 01'st Sep 2022 Benzinga
Gainers
Nuwellis, Inc. (NASDAQ: NUWE) shares climbed 121.3% to close at $1.46 on Wednesday after the company announced new clinical data demonstrating 100% survival at 30 days following the use of ul
This Women Health Stock Gets Analyst Downgrade On 'Approvability Issues, Restructuring'
06:56pm, Tuesday, 30'th Aug 2022 Benzinga
HC Wainwright has downgraded ObsEva SA (NASDAQ: OBSV) from a Buy to Neutral without a price target.
Late last month, the FDA notified ObsEva of review issues regarding deficiencies in the linzag
